Charity News from Friday, Jan. 28, 2000Study Shows Greater Risk of Breast Cancer with Estrogen-Progestin Therapy Compared to Estrogen AloneNational Cancer Institute | Researchers from the National Cancer Institute (NCI) in Bethesda, Md., have found that combined estrogen-progestin replacement therapy is associated with a greater risk of breast cancer than estrogen alone. (Relative risk calculates the risk of ... Newly discovered death signal could hold key to eradicating deadly bacteria St. Jude Children's Research Hospital (ALSAC) | Scientists at St. Jude Children's Research Hospital have discovered a death signal that brings about the death of Streptococcus pneumoniae (also known as pneumococcus) - a discovery that could lead to revolutionary new treatments for the killer ... Invited to State of the Union Address, Two Navajo Tribal College Students Honored for Commitment to Teaching & Community Service American Indian College Fund | Christina and Justina Jones, students at Din‚ College in Tsaile, Arizona, were recognized for their commitment to teaching and community service. The American Indian College Fund has supported Indian teacher development through the Tribal College... Cancer priorities high in State of the Union remarks, says American Cancer Society American Cancer Society | Washington - January 28, 2000 -Delivering the State of the Union last night, President Clinton highlighted many issues which touch those affected by cancer. "In particular, the American Cancer Society is pleased President Clinton renewed his call... Aspirin Once Again Proven to be Effective Prevention Against Heart Attacks Duke University Medical Center | In the first head-to-head comparison against one of the newest oral heart drugs, aspirin has been shown to be just as effective in preventing heart attacks and had fewer bleeding side effects. Yale Testing New Drug to Treat Leading Cause of Blindness in People Over 50 Yale School of Medicine | A new light sensitive drug used to treat the most severe form of macular degeneration, which is the leading cause of blindness in people over 50, is being tested at Yale School of Medicine.
|
|
